ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jun 4, 2012
Bristol-Myers Squibb Cancer Drug Shows Promise
A new drug that shrinks tumors in lung cancer patients exemplifies Bristol-Myers' aggressive cancer treatment pipeline. However, we think its stock is expensive at current levels.
Jun 4, 2012
How Would a Double Dip Impact Retailers?
Though we don't think a double-dip recession in the US is around the corner, we outline our views on how the general economy and employment trends impact same-store-sales performance across the consumer spectrum.
Jun 1, 2012
Valuentum's June Edition of Its Dividend Growth Newsletter!
The June edition of our Dividend Growth Newsletter is now available!
May 30, 2012
'The Avengers' Success Bodes Well for Dividend-Growth Gem Hasbro
Dividend-growth portfolio holding Hasbro reported lackluster first-quarter results in April, but the company's recent success of 'The Avengers' could propel earnings in the second and third quarters ahead of consensus estimates. We think Hasbro looks very compelling at current levels.
May 30, 2012
Monsanto Raises Earnings and Cash-Flow Guidance
The world's largest seed company offered an optimistic outlook for both the remainder of its fiscal 2012 and fiscal 2013. We'll be taking a look at our fair value estimate for Monsanto and expect to raise it modestly on the news.
May 30, 2012
RIM Likely to Post First-Quarter Loss, Seeks Strategic Options
Research In Motion's shares look cheap, but its technicals and momentum indicators are atrocious. We're staying away from this potential value trap.
May 29, 2012
Revisiting Roundy’s: Dividend Now In Play
Roundy's has declared what seems to be an unsustainable dividend payout, but the firm may still experience significant capital appreciation.
May 25, 2012
Tiffany Issues Weak First-Quarter Results; Cuts Full-Year Outlook
Tiffany reported disappointing first-quarter results that showed decent revenue expansion but weak bottom-line performance. Though we expect to ratchet down our near-term earnings expectations, we don't expect to make a material change to our fair value estimate.
May 24, 2012
Hewlett Packard’s Second-Quarter Results Exceed Expectations; Major Changes on the Way
Hewlett-Packard posted strong second-quarter results that came in better than consensus expectations. We're optimistic on HP's restructuring plans as well as the company's dirt cheap valuation. However, peers like Intel and Microsoft look like much more attractive investments with better growth potential and near-term catalysts. Both companies also provide investors with better, safer yields, as we think both are best-in-class in chips and enterprise software, respectively.
May 23, 2012
Dell's First-Quarter Performance Weighed Down by Encroaching Tablet Competition
Dell reported terrible first-quarter results, and we are putting our fair value estimate of the computer maker under review. Though we expect to lower it materially, we maintain that the firm's shares are significantly underpriced at today's levels. However, we prefer Apple in the portfolio of our Best Ideas Newsletter.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.